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Positron Emission Tomography (PET) is an imaging technique that provides functional
information, in addition to structural information obtained with computed tomography
(CT). The most common application is cancer staging, using 18F-Fluorodeoxyglucose
(18F-FDG), a radioactive analog of glucose. Although limited data are available in
the veterinary literature, human studies have demonstrated benefit with the addition
of PET both for assessment of the primary tumor and for detection of metastatic
disease. 18F-FDG PET appears to be more accurate at detecting the margin of oral
neoplasia, in particular for tumors arising from highly vascularized tissue, such as the
lingual and laryngeal areas. 18F-FDG PET has a high sensitivity for the detection of
lymph node metastasis, however the specificity is variable between studies. Tracers
beyond 18F-FDG can also be used for oncology imaging. 18F-Fluoride (18F-NaF) is an
excellent osseous tracer, useful in assessing bone involvement of primary tumors or
osseous metastasis. Other specific tracers can be used to assess cell proliferation or
hypoxia for tumor characterization. 18F-FDG is also an excellent tracer for detection
of inflammation. Human studies have demonstrated its value for the assessment of
periodontitis and dental implant infection. 18F-NaF has been used to assess disorders of
the temporomandibular joint in the human literature, demonstrating good correlation with
arthralgia and therapeutic outcome. Both 18F-NaF and 18F-FDG had good concordance
with localization of cervical pain in people. PET will likely have a growing role in veterinary
medicine not only for oncologic imaging but also for assessment of inflammation
and pain.
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INTRODUCTION
Positron Emission Tomography (PET) is a nuclear medicine imaging technique, which provides
cross-sectional data based on the 3-dimensional localization of positrons emitted by radiotracers.
When compared with scintigraphy, in addition to its cross-sectional nature, PET has the advantages
of higher detection efficiency and spatial resolution (1). PET data reflects the distribution of the
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radiotracer in the area being imaged, but does not provide
structural information relating to the anatomy of the patient.
Rather, PET provides functional information based on the
interaction of the radiotracers at the molecular level in relation to
physiological events. In order to facilitate anatomic localization
of areas of increased radiotracer uptake, PET is usually combined
with computed tomography (CT), which provides structural
information of the patient. Quantification of the radiotracer
uptake is commonly reported in PET studies using the maximal
standardized uptake value (SUVmax), which is calculated based
on the injected dose corrected for decay at the time of imaging
and weight of the patient.
A broad choice of radiotracers is available for PET. 18F-
Fluoride is the most commonly used positron emitter. The 2-
h half-life is convenient for clinical use and fluoride can be
easily integrated into various organic molecules in place of a
hydroxyl group. The most commonly used radiotracer is 18F-
Fluorodeoxyglucose (18F-FDG), which is a radioactive analog
of glucose. Similar to glucose, FDG is actively transported into
cells by a group of structurally related glucose transport proteins.
For this reason, 18F-FDG is an excellent marker of metabolic
activity and is particularly useful for the detection of neoplasia, as
tumor cells often preferentially utilize glucose for glycolysis and
subsequently display increased numbers of glucose transporters
(2). Cancer staging is by far the most common application of PET
imaging using 18F-FDG. However, 18F-FDG uptake is not only
found in neoplastic tissue but also in areas of inflammation (3).
Another commonly used tracer is 18F-Fluoride (18F-NaF).
18F-NaF is an excellent marker of bone remodeling as it gets
integrated into the exposed hydroxyapatite matrix at sites of bone
turnover. 18F-NaF has a higher sensitivity than the larger and
FIGURE 1 | Transverse post-contrast CT (left) and fused 18F-FDG PET/CT (right) images through the caudal aspect of the nasal cavity of a 10-year-old male
castrated standard poodle presented for staging of nasal adenocarcinoma. There is a large soft tissue mass filling the left side of the nasal cavity and resulting in
destruction of the nasal turbinates and invasion of the maxillary recess. The soft tissue opacity extends ventrally into the rostral aspect of the nasopharynx. The
opacity in the nasopharynx is strongly contrast enhancing on the CT image but does not show FDG uptake whereas the rest of the mass demonstrates strong FDG
uptake. This suggests that the tissue in the nasopharynx differs from the bulk of the tumor and might represent edematous nasopharyngeal mucosa rather than
neoplastic tissue.
more complex 99mTc-Bisphosphonates used for scintigraphic
imaging. 18F-NaF has been commonly used in oncology for the
detection of primary osseous tumors or metastasis but can also
be used for non-oncologic imaging (4).
PET availability remains limited in the veterinary field, with
only a few academic institutions offering clinical PET imaging,
but there is a growing interest in the technique based on recent
publications. Similar to the human field, oncologic applications
largely dominate the clinical use of PET, but other indications are
being considered.
ONCOLOGIC PET IMAGING OF HEAD
AND NECK
The veterinary literature describes the use of PET for staging
of several canine and feline tumors. One study examined oral
squamous cell carcinoma in 12 feline patients (5, 6). The oral
tumors were more conspicuous on PET than on contrast CT
(5). PET also identified hypermetabolic tissue considered to be
potentially neoplastic outside of the suspected neoplastic area
recognized with CT (5). This was more commonly identified in
patients with smaller ill-defined lesions on CT, in particular if
their tumors arose from the lingual, pharyngeal, and laryngeal
regions rather than the mandibular and maxillary areas (6).
Interestingly, the measured tumor volume was smaller on PET
than on contrast CT in the majority of patients. (6) This is similar
to observations in a human study that demonstrated a smaller
volume of pharyngolaryngeal squamous cell carcinomameasured
with FDG PET when compared with CT and MRI, with a
difference in volume ranging from 28 to 37%. Surgical correlation
demonstrated that all imaging modalities overestimated the size
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FIGURE 2 | Multiplanar reformat CT (top) and fused 18F-FDG PET (bottom) images through the maxilla of a 12-year-old Australian Cattle Dog presenting for staging
of a previously resected oral melanoma. There is vertical and horizontal bone loss involving the left canine and left maxillary premolars 1, 2, and 3. Marked focal
18F-FDG uptake (long arrow) is present at the distal aspect of the left maxillary canine. Additional resorptive areas are present adjacent to the three most mesial
premolars, the lack of 18F-FDG uptake in this area suggest that there is no active inflammation at this level. The marked 18F-FDG uptake at the buccal aspect of
premolars 3 and 4 is at the site of previous resection of an oral melanoma and likely indicate regrowth or residual tumor tissue. This case illustrates the sensitivity of
18F-FDG PET to distinguish between active and inactive periodontal disease and to identify abnormal tissue at the site of previous tumor resection. It also
demonstrates the lack of specificity and the need to interpret the images based on associated CT findings and clinical history. Note that the high spatial resolution
(∼2mm) on the compact scanner (piPET, Brain Biosciences, Inc) is key in identifying these small lesions.
of the tumor, but PET was the most accurate modality (7). The
increased accuracy in definitions of the margin is of particular
importance for treatment planning, both for surgery or radiation
therapy. Better margin definitions are more likely to yield to
successful surgical outcomes and improve targeted delivery of
radiations. An example of the comparison between CT alone
and fused FDG PET with CT in a patient with nasal carcinoma
imaged at our institution using a high-resolution PET scanner
(piPET, BrainBiosciences, Inc.) is provided in Figure 1. The
difference observed between contrast CT and 18F-FDG PET can
be explained by the type of information provided. Contrast CT
highlights areas with increased perfusion, whereas 18F-FDG PET
identifies areas with high metabolic activity. 18F-FDG PET can
be advantageous in areas that are normally highly vascularized
where contrast CT is less likely to demonstrate a difference
between a tumor with increased blood perfusion and the highly
vascularized background (6).
In addition to 18F-FDG PET, 18F-NaF PET has been suggested
for assessment of bone involvement in cancer (4). A comparative
study between 18F-FDG and 18F-NaF PET demonstrated a
superior correlation with histopathology for 18F-NaF. (8) Further
characterization of tumor biological activity can be achieved
using specific tracers. This is of particular interest to optimize
treatment planning. For example, 18F-deoxyfluorothymidine
Frontiers in Veterinary Science | www.frontiersin.org 3 June 2019 | Volume 6 | Article 180
Spriet et al. PET Imaging of Head and Neck
(18F-FLT) and 61Cu-diacetylmethylthiosemicarbazone (61Cu-
ATSM), are markers of tumor proliferation and hypoxia,
respectively, which are useful indicators of tumor sensitivity
to radiation (9). Twenty dogs with sinonasal tumors were
imaged with 18F-FDG, 18F-FLT, and 61Cu-ATSM. Heterogeneity
with regard to proliferation and hypoxia of the tumors was
demonstrated. Carcinomas demonstrated strong correlations
between the standardized uptake values of the three tracers,
whereas sarcomas were less likely to correlate (10). 18F-fluoro-
misonidazole (18F-miso) is another marker of hypoxia used in
human studies (11) with potential applications in veterinary
medicine (12).
PET/CT has been used extensively in the detection of local
and distant metastasis. In the feline oral squamous cell carcinoma
study, only limited cytologic confirmation of metastasis was
available, however out of three cytologically confirmed lymph
node metastasis, two were identified based on PET findings, but
were not apparent on contrast CT (5). To our knowledge, larger
studies looking at the accuracy of PET for detection of lymph
node metastasis are lacking in the veterinary literature. Human
literature often concludes a higher accuracy of PET compared
with CT alone regarding metastasis detection but a wide range of
results have been reported (13–18). This suggests that tumor type,
tumor locations, and imaging techniques likely affect outcome.
There is an overall trend toward higher sensitivity of PET for
metastasis detection when compared with CT and MRI, but
some studies identify a lack of specificity (13, 17). PET findings
should be interpreted in conjunction with clinical presentation
and other imaging findings to optimize the accuracy and reduce
false positives. Species and tumor specific studies are needed
in the veterinary literature to elucidate the value of PET and
whether it could be considered a less invasive alternative to lymph
node sampling.
NON-ONCOLOGIC PET IMAGING OF HEAD
AND NECK
There are limited reports evaluating the use of PET in non-
oncologic applications in the veterinary literature. The most
common use of PET for the detection of inflammation relates
to neurologic disease (19), but 18F-FDG PET was also useful
in a case of Blastomyces dermatitis, as well as cases with a
fever of unknown origin (20, 21). Orthopedic uses of PET have
recently gained interest in veterinary medicine. The use of 18F-
FDG has been proposed for lameness evaluation in a dog (22).
Recently, PET has been introduced to equine lameness imaging
with the use of 18F-NaF PET for assessment of active bone
remodeling (23–25).
In the human literature, there are various interesting
applications for non-oncologic PET imaging of the head and
neck. A few reports have assessed the value of 18F-FDG PET
for identification of periodontal disease or apical periodontitis
(26–28). Although 18F-FDG PET had not been performed for
the primary purpose of periodontal assessment, these studies
demonstrated that useful information regarding the oral cavity
can be obtained when patients are imaged with PET for other
indications. Similar observations exist in canine patient. Figure 2
is an example of a dog imaged with high-resolution PET for
tumor assessment and demonstrates active periodontal disease. A
recent study in people investigated the use of PET for assessment
of dental implants and concluded that functional imaging using
18F-FDG could become a new tool for the assessment of peri-
implant diseases (29).
18F-NaF PET has been suggested for assessment of
temporomandibular joint disorders (30, 31). Previous studies in
human medicine have demonstrated a superior ability to detect
osteoarthritis of the temporomandibular joint when compared
with 99mTc-MDP bone scintigraphy (30). Furthermore, SUVmax
appeared to correlate with arthralgia and therapeutic outcome
(30). 18F-NaF PET imaging has also been used for assessment
of neck pain. Although the high background vertebral uptake
can be a limitation, PET was still considered beneficial in a study
for 84.5% of the 58 patients with neck pain (32). 18F-FDG PET
also appeared useful as guidance for therapy in patients with
cervical facet syndrome. In a study involving 140 facet joints,
100% concordance was found between location of focal 18F-FDG
uptake and painful area in the neck (33).
In conclusion, PET is best known for its use in oncologic
staging, however the array of radiotracers available provide a
diverse set of applications. The functional properties of the
technique apply to not only the metabolic activity of tumors but
also the assessment of bone remodeling, inflammation, and pain.
With changes in technology, including the decreased cost and
the availability of high resolution PET scanners, it is likely that
the use of PET in veterinary medicine will experience continued
growth in the future.
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